Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 7;50(11):5961-71.
doi: 10.1021/acs.est.6b00374. Epub 2016 May 12.

Evaluating the Impact of Uncertainties in Clearance and Exposure When Prioritizing Chemicals Screened in High-Throughput Assays

Affiliations

Evaluating the Impact of Uncertainties in Clearance and Exposure When Prioritizing Chemicals Screened in High-Throughput Assays

Jeremy A Leonard et al. Environ Sci Technol. .

Abstract

The toxicity-testing paradigm has evolved to include high-throughput (HT) methods for addressing the increasing need to screen hundreds to thousands of chemicals rapidly. Approaches that involve in vitro screening assays, in silico predictions of exposure concentrations, and pharmacokinetic (PK) characteristics provide the foundation for HT risk prioritization. Underlying uncertainties in predicted exposure concentrations or PK behaviors can significantly influence the prioritization of chemicals, though the impact of such influences is unclear. In the current study, a framework was developed to incorporate absorbed doses, PK properties, and in vitro dose-response data into a PK/pharmacodynamic (PD) model to allow for placement of chemicals into discrete priority bins. Literature-reported or predicted values for clearance rates and absorbed doses were used in the PK/PD model to evaluate the impact of their uncertainties on chemical prioritization. Scenarios using predicted absorbed doses resulted in a larger number of bin misassignments than those scenarios using predicted clearance rates, when comparing to bin placement using literature-reported values. Sensitivity of parameters on the model output of toxicological activity was examined across possible ranges for those parameters to provide insight into how uncertainty in their predicted values might impact uncertainty in activity.

PubMed Disclaimer

Conflict of interest statement

Notes

The authors declare the following competing financial interest(s): Daniel Chang is employed by the Chemical Computing Group in Montreal, Canada, the publisher of the Molecular Operating Environment (MOE) software.

Figures

Figure 1
Figure 1
Categories of acetylcholinesterase inhibiting chemicals used as a case study for prioritization, along with their in vitro potencies. Abbreviations are as follows: DDAC, didecyldimethylammonium chloride; 2,4-TDI, toluene 2,4-diisocyanate; DBSA, dodecylbenezene sulfonic acid.
Figure 2
Figure 2
Decision tree for selecting category of chemical of interest (A) and the appropriate pharmacokinetic (PK) and pharmacodynamic (PD) model inputs and parameters for that chemical category (B). The open circle in (A) represents a diverging step. Shaded boxes in (B) represent a need for the model input or parameter for that chemical category, whereas empty boxes represent exclusion of that parameter from the model. See text for how parameters were used in the PK and PD model.

References

    1. Abt E, Rodricks JV, Levy JI, Zeise L, Burke TA. Science and Decisions: Advancing Risk Assessment. Risk Anal. 2010;30(7):1028–1036. - PubMed
    1. Krewski D, Andersen ME, Mantus E, Zeise L. Toxicity testing in the 21st century: Implications for human health risk assessment. Risk Anal An Off Publ Soc Risk Anal. 2009;29(4):474–479. - PubMed
    1. Hau J, Schapiro SJ, Jr, GL VH. Handbook of Laboratory Animal Science: Animal Models. 2. CRC Press; Boca Raton: 2002.
    1. MacIntosh DL, Spengler JD, Gutschmidt K, Lyle K. Human Exposure Assessment; Environmental Health Criteria Monograph 214. International Programme on Chemical Safety; Geneva, Switzerland: 2000.
    1. Risk assessment forum white paper: Probabalistic risk assessment methods and case studies; Highlights of EPA/100/R-14/004. United States Environmental Protection Agency Office of the Science Advisor; Washington, DC: 2014. [15 Dec 2015]. http://www.epa.gov/sites/production/files/2014-12/documents/raf-pra-whit....

Publication types

LinkOut - more resources